The Archive | Wild West & Peptides

1. Front Page & Supplier Documentation Comparisons

Wild West & Peptides Front Page — Investigative overview of the research-peptide market, COA verification standards, and supplier documentation benchmarks.
Supplier Documentation Comparison (The Honest Vendor Audit) — Documentation comparison of the suppliers covered in the audit.
Peptide Vendor Rankings — Supplier categories and our five-area unweighted documentation checklist.
Evaluating Research Peptide Value & Documentation — Why COA verification, net peptide content, and evidence quality matter when comparing apparent value.
Common Peptide Scams to Avoid — How fake COAs, under-dosed vials, cloned sites, and payment traps operate in the peptide market.
Vendor Red Flags — Twelve warning signs grouped by severity to check before trusting a supplier catalog.

BPC-157 Real Talk: Rodent Studies vs. Human Evidence — Review of BPC-157 preclinical literature, publication concentration, and FDA status: nominated for Category 2 but withdrawn.
BPC-157 Suppliers Compared — Comparing supplier COA availability, testing verification, and documentation for BPC-157.
TB-500 Suppliers Compared — Comparing supplier COA documentation and fragment vs. full-length Thymosin Beta-4 distinctions.
CJC-1295 Suppliers Compared — Comparing CJC-1295 without DAC (Mod GRF 1-29) and CJC-1295 with DAC supplier documentation.
Ipamorelin Suppliers Compared — Comparing supplier COA availability and third-party verification for Ipamorelin.
GHK-Cu Suppliers Compared — Comparing lyophilized and topical GHK-Cu supplier documentation and third-party COA records.

Do Peptides Actually Work? An Evidence Audit — Grading compounds across human RCTs, mechanism studies, animal models, and unproven claims.
Peptide Myths Busted — Examining common peptide misconceptions against analytical chemistry, clinical data, and regulatory rules.
Peptide Side Effects & Unknowns — Reviewing compound-specific adverse events, contamination risks, and long-term safety gaps.
Peptide Co-Administration & Stacking Evidence Review — Distinguishing complementary mechanisms from demonstrated synergy and unstudied combinations.
DIY Protocols: Evidence and Risks — Why non-clinical peptide preparation, sterility blind spots, and storage errors carry serious risk.
Self-Experimentation Risk & Evidence Framework — Why informal anecdotes and uncontrolled N-of-1 observations cannot establish general safety or efficacy.
Community Logs: Anecdotal Reports and Their Limits — Qualitative overview of public forum report themes, survivor bias, and placebo confounding.

Peptide Legal Status by Country — Country-by-country overview of commercial sale, possession, import, and prescription rules.
U.S. Peptide Regulation by State — State-by-state overview of federal compounding rules and state enforcement context.
Prescription Requirements & FDA Compounding Rules — FDA-approved peptide medicines vs. Section 503A/503B compounding rules.
Customs & Import Enforcement Guide — International customs screening, detention notices, and cross-border import rules by country.
Peptides in Sports: WADA & League Rules — WADA Prohibited List classifications and anti-doping policies across athletic organizations.

About the Desk — Our editorial charter, five-area unweighted documentation checklist, and reporting standards.
Frequently Asked Questions — Concise answers on peptide evidence, COA verification, and legal status.
Contact & Tips — How to submit factual corrections, broken links, or public COA documentation links.
Privacy Policy — Edge logging, Cloudflare disclosures, and reader correspondence privacy.
Terms of Use — Informational scope, no medical/legal advice, accuracy disclaimers, and limitation of liability.